IC261

Overview

IC261 is a selective, ATP-competitive CK1 inhibitor, with IC 50 s of 1 μM, 1 μM, 16 μM for Ckiδ , Ckiε and Ckiα1, respectively.

Application

Products | Products > Disease Areas > Digestive System Inflammation | Products > Disease Areas > Inflammation or Immune System Disease | Products > Disease Areas > Cancer | Products > Disease Areas > Digestive System Disease | Products > Signaling Pathways > Cell Cycle/DNA Damage | Products > Signaling Pathways > Stem Cell/Wnt | Products > Signaling Pathways > Apoptosis | Products > Research Areas > Cancer | Products > Research Areas > Cancer > Cancer Targeted Therapy | Products > Research Areas > Cancer > Cancer Stem Cells | Products > Research Areas > Cancer > Cancer Metabolism and Metastasis | Products > Signaling Pathways > Casein Kinase | Products > Signaling Pathways > Apoptosis

Product Information

• Catalog No.: HY-12774
• CAS No.: 186611-52-9
• Molecular Formula: C18H17NO4
• Molecular Weight: 311.33
• Purity: 99.63%
• Storage: Powder -20°C, 3 years , 4°C, 2 years ; In solvent -80°C, 2 years , -20°C, 1 year
• Solubility: ≥ 2.5 mg/mL (8.03 mM); Clear solution
• Availability: In-stock

Source

Original product source